Asia Medical Agricultural Stock Price To Earnings To Growth
| AMARC Stock | 1.38 0.04 2.82% |
Asia Medical Agricultural fundamentals help investors to digest information that contributes to Asia Medical's financial success or failures. It also enables traders to predict the movement of Asia Stock. The fundamental analysis module provides a way to measure Asia Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Asia Medical stock.
Asia |
Asia Medical Agricultural Company Price To Earnings To Growth Analysis
Asia Medical's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, Asia Medical Agricultural has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Technology sector and 100.0% lower than that of the Scientific & Technical Instruments industry. The price to earnings to growth for all Thailand stocks is 100.0% higher than that of the company.
Did you try this?
Run Bonds Directory Now
Bonds DirectoryFind actively traded corporate debentures issued by US companies |
| All Next | Launch Module |
Asia Fundamentals
| Profit Margin | 0.1 % | |||
| Operating Margin | 0.14 % | |||
| Current Valuation | 1.47 B | |||
| Shares Outstanding | 420 M | |||
| Shares Owned By Insiders | 73.64 % | |||
| Price To Book | 5.93 X | |||
| Price To Sales | 4.48 X | |||
| Revenue | 271.77 M | |||
| Gross Profit | 109.51 M | |||
| EBITDA | 62.16 M | |||
| Book Value Per Share | 0.71 X | |||
| Earnings Per Share | 0.08 X | |||
| Number Of Employees | 221 | |||
| Market Capitalization | 1.23 B | |||
| Last Dividend Paid | 0.05 |
About Asia Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Asia Medical Agricultural's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Asia Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Asia Medical Agricultural based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Asia Stock
Asia Medical financial ratios help investors to determine whether Asia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Asia with respect to the benefits of owning Asia Medical security.